Table 3

Characteristics of the participants in the second screening step (n = 1,712) by Finnish Diabetes Risk Score (FINDRISC) classes including glucose and hemoglobin (Hb)A1c findings

Parameter

FINDRISC classes

Total

p


<7

7 to 11

12 to 14

15 to 20

>20


Number of participants, n

98 (5.7)

475 (27.7)

416 (24.3)

633 (37.0)

90 (5.3)

1712

-

Sex, men

29 (29.6)

174 (36.6)

135 (32.5)

212 (33.5)

19 (21.1)

569 (33.2)

0.06

Age, years

55.0 ± 7.5

60.1 ± 8.2

60.4 ± 8.0

62.0 ± 8.0

61.8 ± 8.4

60.7 ± 8.2

<0.01

45-54

53 (54.1)

147 (30.9)

114 (27.4)

129 (20.4)

21 (23.3)

464 (27.1)

55-64

34 (34.7)

172 (36.2)

160 (38.5)

244 (38.5)

30 (33.3)

640 (37.4)

>65

11 (11.2)

156 (32.8)

142 (34.1)

260 (41.1)

39 (43.3)

608 (35.5)

BMI, kg/m2

23.8 ± 2.4

27.6 ± 3.9

29.7 ± 4.5

31.5 ± 4.2

33.6 ± 4.4

29.7 ± 4.7

<0.01

< 25

70 (71.4)

107 (22.5)

41 (9.9)

19 (3.0)

3 (3.3)

240 (14.0)

25-30

27 (27.6)

281 (59.2)

208 (50.0)

215 (34.0)

9 (10.0)

740 (43.2)

≥ 30

1 (1.0)

87 (18.3)

167 (40.1)

399 (62.7)

78 (86.7)

732 (42.8)

Waist circumference, cm

81.7 ± 7.7

93.2 ± 10.6

97.9 ± 10.8

101.8 ± 9.8

105.2 ± 9.6

97.4 ± 11.5

<0.01

M<94, F<80

72 (73.5)

86 (18.1)

24 (5.8)

11 (1.7)

0 (0.0)

193 (11.3)

M 94-102, F 80-88

26 (26.5)

186 (39.2)

113 (27.2)

137 (21.6)

1 (1.1)

463 (27.0)

M ≥103, F ≥89

0 (0.0)

203 (42.7)

279 (67.1)

485 (76.6)

89 (98.9)

1056 (61.7)

Systolic blood pressure, mmHg

122.8 ± 14.5

130.7 ± 15.1

132.7 ± 15.7

134.8 ± 14.9

138.3 ± 16.7

132.6 ± 15.5

<0.01

Diastolic blood pressure, mmHg

73.7 ± 7.9

77.4 ± 8.7

79.4 ± 16.8

79.7 ± 9.1

81.9 ± 9.2

78.8 ± 11.4

<0.01

FINDRISC items

Antihypertensive medication

6 (6.1)

136 (28.6)

170 (40.9)

394 (62.2)

66 (73.3)

772 (45.1)

<0.01

Physical activity

81 (82.7)

389 (81.9)

296 (71.2)

416 (65.7)

36 (40.0)

1218 (71.1)

<0.01

Consumption of vegetables/fruits

81 (82.7)

428 (90.1)

358 (86.1)

540 (85.3)

75 (83.3)

1482 (86.6)

0.09

History of blood glucose disorders

0 (0.0)

17 (3.6)

60 (14.4)

277 (43.8)

88 (97.8)

442 (25.8)

<0.01

Family history, first degree

4 (4.1)

46 (9.7)

65 (15.6)

74 (11.7)

4 (4.4)

193 (11.3)

<0.01

Family history, other degree

0 (0.0)

88 (18.5)

172 (41.3)

404 (63.8)

83 (92.2)

747 (43.6)

<0.01

2-hour Plasma glucose, mmol/l

5.3 ± 2.0

6.2 ± 2.3

6.4 ± 2.6

7.4 ± 3.0

9.4 ± 3.2

6.8 ± 2.8

<0.01

Diabetes

1 (1.0)

24 (5.1)

23 (5.5)

81 (12.8)

29 (32.2)

158 (9.2)

Pre-diabetes

7 (7.1)

87 (18.3)

75 (18.0)

172 (27.2)

39 (43.3)

380 (22.2)

Fasting plasma glucose, mmol/l

4.7 ± 0.5

5.0 ± 0.8

5.1 ± 1.0

5.4 ± 1.1

6.0 ± 1.3

5.2 ± 1.0

<0.01

Diabetes

0 (0.0)

7 (1.5)

10 (2.4)

28 (4.4)

8 (8.9)

53 (3.1)

Pre-diabetes

6 (6.1)

83 (17.5)

80 (19.2)

210 (33.2)

53 (58.9)

432 (25.2)

HbA1c (NGSP),%b

5.3 ± 0.5

5.4 ± 0.5

5.4 ± 0.6

5.5 ± 0.6

5.8 ± 0.5

5.5 ± 0.6

<0.01

HbA1c (IFCC), mmol/molb

34.3 ± 5.3

35.2 ± 5.9

36.0 ± 6.2

37.1 ± 6.9

40.1 ± 5.8

36.3 ± 6.4

<0.01

Diabetes

1 (1.0)

9 (1.9)

9 (2.2)

33 (5.2)

10 (11.1)

62 (3.6)

Pre-diabetes

22 (22.4)

114 (24.0)

107 (25.7)

150 (23.7)

36 (40.0)

429 (25.1)


aData are means ± SE for quantitative variables or n (%) for qualitative variables.

bHbA1c values have been indicated in accordance with both the National Glycohemoglobin Standardization Program (NGSP) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) criteria.

Costa et al. BMC Medicine 2013 11:45   doi:10.1186/1741-7015-11-45

Open Data